These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6737164)

  • 21. Praziquantel and the benzodiazepine Ro 11-3128 do not compete for the same binding sites in schistosomes.
    Pica-Mattoccia L; Ruppel A; Xia CM; Cioli D
    Parasitology; 2008 Jan; 135(Pt 1):47-54. PubMed ID: 17767796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Praziquantel in the treatment of schistosomiasis mansoni].
    Prata A; Castro N; Silva AE; Paiva M; Macêdo V; Junqueira LF
    Rev Inst Med Trop Sao Paulo; 1982; 24(2):95-103. PubMed ID: 6753087
    [No Abstract]   [Full Text] [Related]  

  • 24. Praziquantel: mode of action.
    Harder A; Andrews P; Thomas H
    Biochem Soc Trans; 1987 Feb; 15(1):68-70. PubMed ID: 3493930
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic analysis of praziquantel resistance in Schistosoma mansoni.
    Liang YS; Dai JR; Zhu YC; Coles GC; Doenhoff MJ
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):274-80. PubMed ID: 12971549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Praziquantel, potassium and 2,4-dinitrophenol: analysis of their action on the musculature of Schistosoma mansoni.
    Fetterer RH; Pax RA; Bennett JL
    Eur J Pharmacol; 1980 May; 64(1):31-8. PubMed ID: 7449814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni.
    Guglielmo S; Cortese D; Vottero F; Rolando B; Kommer VP; Williams DL; Fruttero R; Gasco A
    Eur J Med Chem; 2014 Sep; 84():135-45. PubMed ID: 25016371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Observation on tegument damage of Schistosoma japonicum and penetration of host leukocytes into the worm body caused by pyquiton].
    Xiao SH; Yang YQ; Yang HZ; Guo HF; Shao BR
    Yao Xue Xue Bao; 1983 Apr; 18(4):241-6. PubMed ID: 6624466
    [No Abstract]   [Full Text] [Related]  

  • 29. Tegument changes of Schistosoma japonicum and Schistosoma mansoni in mice treated with artemether.
    Xiao SH; Shen BG; Horner J; Catto BA
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):535-7. PubMed ID: 9863150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered behaviour of carbohydrate-bound molecules and lipids in areas of the tegument of adult Schistosoma mansoni worms damaged by praziquantel.
    Lima SF; Vieira LQ; Harder A; Kusel JR
    Parasitology; 1994 Nov; 109 ( Pt 4)():469-77. PubMed ID: 7800415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Praziquantel has no direct effect on (Na(+)+K+)-ATPases and (Ca2(+)-Mg2+)ATPases of Schistosoma mansoni.
    Cunha VM; Noël F
    Life Sci; 1997; 60(20):PL 289-94. PubMed ID: 9150424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oxamniquine and praziquantel on cell mediated immunity in intestinal bilharziasis.
    Madwar MA; El-Fekhakh EA; Montasser MF; Hussein MM; Ahmed MS; Ahmed SE
    J Egypt Soc Parasitol; 1983 Jun; 13(1):277-83. PubMed ID: 6631107
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the mechanism of the antischistosomal action of praziquantel].
    Xiao SH
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(3):196-8. PubMed ID: 6509755
    [No Abstract]   [Full Text] [Related]  

  • 34. Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    Ann Trop Med Parasitol; 2001 Oct; 95(7):715-23. PubMed ID: 11784425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Praziquantel inhibits Schistosoma mansoni attachment in vitro.
    da-Silva SP; Noel F
    Braz J Med Biol Res; 1990; 23(10):1005-8. PubMed ID: 2101049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bimodal X-ray and Infrared Imaging of an Organometallic Derivative of Praziquantel in Schistosoma mansoni.
    Clède S; Cowan N; Lambert F; Bertrand HC; Rubbiani R; Patra M; Hess J; Sandt C; Trcera N; Gasser G; Keiser J; Policar C
    Chembiochem; 2016 Jun; 17(11):1004-7. PubMed ID: 26991635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The schistosome excretory system: a key to regulation of metabolism, drug excretion and host interaction.
    Kusel JR; McVeigh P; Thornhill JA
    Trends Parasitol; 2009 Aug; 25(8):353-8. PubMed ID: 19617001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses of the surface membrane and excretory system of Schistosoma mansoni to damage and to treatment with praziquantel and other biomolecules.
    Oliveira FA; Kusel JR; Ribeiro F; Coelho PM
    Parasitology; 2006 Mar; 132(Pt 3):321-30. PubMed ID: 16318676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schistosoma mansoni: activity responses in vitro to praziquantel.
    Chavasse CJ; Brown MC; Bell DR
    Z Parasitenkd; 1979 Feb; 58(2):169-74. PubMed ID: 433384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination.
    William S; Botros S
    Int J Parasitol; 2004 Jul; 34(8):971-7. PubMed ID: 15217736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.